Anastasia Amiramova
Psychiatric/Mental Health · Saint Louis, MONPI 1982327987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 24.9% of the total. Among psychiatric/mental health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $29.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$772
- Alkermes, Inc.$674
- E.r. Squibb & Sons, L.L.C.$643
- Vanda Pharmaceuticals Inc.$522
- plus $3K from 24 others
What the payments were for
- Food & beverage$8,77197%
- Education$2483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 90 | $2,250 |
| Teva Pharmaceuticals USA, Inc. | 28 | $1,161 |
| AbbVie | 26 | $772 |
| Alkermes, Inc. | 22 | $674 |
| E.r. Squibb & Sons, L.L.C. | 27 | $643 |
| Vanda Pharmaceuticals Inc. | 9 | $522 |
| Harmony Biosciences LLC | 14 | $464 |
| Axsome Therapeutics, Inc. | 16 | $455 |
| Tris Pharma Inc | 15 | $270 |
| Acadia Pharmaceuticals Inc | 5 | $258 |
| Neurocrine Biosciences, Inc. | 19 | $257 |
| Luye Pharma (USA) Ltd. | 4 | $198 |
| Johnson & Johnson | 6 | $164 |
| Novo Nordisk | 3 | $150 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Noven Pharmaceuticals, Inc. | 1 | $123 |
| Bioxcel Therapeutics, Inc. | 1 | $120 |
| Noven Therapeutics, LLC | 6 | $90 |
| Avanir Pharmaceuticals, Inc. | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Neos Therapeutics, LP | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| Lilly USA, LLC | 1 | $25 |
| Lundbeck LLC | 1 | $20 |
| TMS Neurohealth Centers Inc. | 1 | $19 |
| Indivior Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,432
- CAPLYTA$1,072
- UZEDY$475
- Fanapt$471
- ARISTADA$424
- VRAYLAR$360
- Austedo XR$347
- COBENFY$236
- Auvelity$125
- Wegovy$125
- QELBREE$125
- Xelstrym$123
- ERZOFRI EXTENDED-RELEASE$123
- Dyanavel XR$121
- Quillivant$121
- Quillichew ER$121
- IGALMI$120
- ARISTADA INITIO$106
How this compares
$9,019 in reported general payments places this provider in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 17 | $140,852 |
| AristadaAripiprazole Lauroxil | 24 | $72,364 |
| CaplytaLumateperone Tosylate | 29 | $49,805 |
| NuplazidPimavanserin Tartrate | 16 | $39,023 |
| RexultiBrexpiprazole | 18 | $29,235 |
| VraylarCariprazine Hcl | 18 | $24,319 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $22,654 |
| TrintellixVortioxetine Hydrobromide | 26 | $13,475 |
| Lurasidone Hcl | 41 | $5,008 |
| Ramelteon | 14 | $4,029 |
| Duloxetine Hcl | 112 | $3,329 |
| Bupropion XlBupropion Hcl | 131 | $3,314 |
| Divalproex Sodium | 95 | $3,024 |
| Aripiprazole | 62 | $2,867 |
| Haloperidol | 83 | $2,735 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $257 | $140,85217 claims |
| Alkermes, Inc.Aristada | $674 | $72,36424 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,250 | $49,80529 claims |
| Acadia Pharmaceuticals IncNuplazid | $258 | $39,02316 claims |
| AbbVieVraylar | $772 | $24,31918 claims |
| Axsome Therapeutics, Inc.Auvelity | $455 | $22,65419 claims |
| Lilly USA, LLCOlanzapine | $25 | $1,87365 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $693154 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Saint Louis
- Aldijana SacicSaint Louis$510K
- Julie WaterburySaint Louis$135K
- Melinda SmithSaint Louis$13K
- Richard YakimoSaint Louis$10K
- Yevgeniya MykhaylevskaSaint Louis$9K
- Jessica BurichSaint Louis$8K
- Jennifer ArmstrongSaint Louis$8K
- Bonnie HuffSaint Louis$7K
- Jacqueline KirkSaint Louis$6K
- Danielle RoncoSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.